Hagler Mark Arnold

Hagler Mark Arnold is listed in filings as See Remarks at NovaBridge Biosciences. This profile follows SEC Form 4 activity through Apr 28, 2026, including purchase activity. Recent filings connect the profile to NovaBridge Biosciences (NBP). The current snapshot covers public activity from Apr 28, 2026. Reported amounts are shown as $577.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.